A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients
Part of paid clinical trials in Stanford, California.
- Sponsor
- Stanford University
- Study ID
- NCT07676136
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Abdominal Pain
- Disorders of Gut-brain Interaction
- Esophageal Disease
- Inflammatory Bowel Disease (IBD)
- Irritable Bowel Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Gut directed hypnotherapy via telephone intervention — BEHAVIORALParticipants will undergo a self-directed gut-directed hypnosis intervention over the telephone.
- Educational recording — BEHAVIORALParticipants will listen to educational material over the telephone about their gastrointestinal symptoms.
Study Details
The purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and/or nausea will be considered for enrollment.
Key Dates
- Start date
- Jul 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 26 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: HypnosisParticipants will undergo gut-directed hypnotherapy via a phone intervention (10 minute recording, at least once daily while hospitalized) and for as much as participant would like for the 3 month duration of the study.
- Sham Comparator: EducationParticipants will listen to educational recording (10 minute recording, at least once daily while hospitalized) and for as much as participant would like for the 3 month duration of the study.
Primary Outcome Measure
Recruitment rate [ Time Frame: Up to 1 year. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Stanford | California | 94305 | - |
Find similar trials in Stanford, CA
By research site
Related Studies
- Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenPHASE2 · Recruiting · AbbVie · Hot Springs, Arkansas
- A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)PHASE3 · Enrolling By Invitation · AbbVie · Corona, California
- Visible Abdominal DistensionRecruiting · Hospital Universitari Vall d'Hebron Research Institute · Los Angeles, California
- Morphine or Ketamine for AnalgesiaPHASE3 · Not Yet Recruiting · Columbia University · Los Angeles, California